Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05396443 · ClinicalTrials.gov registry record · NA
Telehealth Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
A NA study, sponsored by Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05396443: Completed NA study, sponsored by Cornell University.
NCT05396443 is a NA study that has completed, run by Cornell University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05396443, a NA study, has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week telehealth lifestyle program.
Primary Outcome
Scores are calculated from three 24-hour diet records, range from 0-100. Higher score reflects that higher alignment between one's diet and dietary recommendations from the Dietary Guidelines for Americans.
Interventions
- BEHAVIORAL Black Girls for Wellness Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2025-02-08 |
| Phase | NA |
What the finished NCT05396443 record still lists
NCT05396443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Black Girls for Wellness Telehealth is the first listed.
NCT05396443 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05396443 about?
NCT05396443 is a clinical study titled "Telehealth Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes". The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week telehealth lifestyle program.
What is the current status of trial NCT05396443?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2022-08-15. Estimated completion is 2025-02-08.
What interventions are being tested in trial NCT05396443?
The interventions under investigation include: Black Girls for Wellness Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT05396443?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05396443's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI